A detailed history of Siena Capital LLC transactions in Aerie Pharmaceuticals Inc stock. As of the latest transaction made, Siena Capital LLC holds 8 shares of AERI stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.95 - $9.16 $232 - $430
-47 Reduced 85.45%
8 $0
Q1 2022

May 16, 2022

BUY
$5.64 - $9.8 $310 - $539
55 New
55 $1,000

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Siena Capital LLC Portfolio

Follow Siena Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siena Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Siena Capital LLC with notifications on news.